Your browser doesn't support javascript.
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
Ong, Catherine Wei Min; Migliori, Giovanni Battista; Raviglione, Mario; MacGregor-Skinner, Gavin; Sotgiu, Giovanni; Alffenaar, Jan-Willem; Tiberi, Simon; Adlhoch, Cornelia; Alonzi, Tonino; Archuleta, Sophia; Brusin, Sergio; Cambau, Emmanuelle; Capobianchi, Maria Rosaria; Castilletti, Concetta; Centis, Rosella; Cirillo, Daniela M; D'Ambrosio, Lia; Delogu, Giovanni; Esposito, Susanna M R; Figueroa, Jose; Friedland, Jon S; Ho, Benjamin Choon Heng; Ippolito, Giuseppe; Jankovic, Mateja; Kim, Hannah Yejin; Rosales Klintz, Senia; Ködmön, Csaba; Lalle, Eleonora; Leo, Yee Sin; Leung, Chi-Chiu; Märtson, Anne-Grete; Melazzini, Mario Giovanni; Najafi Fard, Saeid; Penttinen, Pasi; Petrone, Linda; Petruccioli, Elisa; Pontali, Emanuele; Saderi, Laura; Santin, Miguel; Spanevello, Antonio; van Crevel, Reinout; van der Werf, Marieke J; Visca, Dina; Viveiros, Miguel; Zellweger, Jean-Pierre; Zumla, Alimuddin; Goletti, Delia.
  • Ong CWM; Dept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Migliori GB; Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore.
  • Raviglione M; These authors contributed equally.
  • MacGregor-Skinner G; Members of ESGMYC.
  • Sotgiu G; Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy delia.goletti@inmi.it giovannibattista.migliori@icsmaugeri.it.
  • Alffenaar JW; These authors contributed equally.
  • Tiberi S; Centre for Multidisciplinary Research in Health Science, University of Milan, Milan, Italy.
  • Adlhoch C; Global Studies Institute, University of Geneva, Geneva, Switzerland.
  • Alonzi T; Dept of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA.
  • Archuleta S; Clinical Epidemiology and Medical Statistics Unit, Dept of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
  • Brusin S; Sydney Pharmacy School, University of Sydney, Sydney, Australia.
  • Cambau E; Westmead Hospital, Sydney, Australia.
  • Capobianchi MR; Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia.
  • Castilletti C; Members of ESGMYC.
  • Centis R; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Cirillo DM; Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • D'Ambrosio L; Members of ESGMYC.
  • Delogu G; Public Health Emergency Team, European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Esposito SMR; European Centre for Disease Prevention and Control Public Health Emergency team co-authors.
  • Figueroa J; Translational Research Unit, Epidemiology and Preclinical Research Dept, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.
  • Friedland JS; Dept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Ho BCH; Public Health Emergency Team, European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Ippolito G; European Centre for Disease Prevention and Control Public Health Emergency team co-authors.
  • Jankovic M; AP-HP-Lariboisiere, Bacteriologie, Laboratory Associated to the National Reference Centre for Mycobacteria, IAME UMR1137, INSERM, University of Paris, Paris, France.
  • Kim HY; Members of ESGMYC.
  • Rosales Klintz S; Laboratory of Virology, Epidemiology and Preclinical Research Dept, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.
  • Ködmön C; Laboratory of Virology, Epidemiology and Preclinical Research Dept, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.
  • Lalle E; Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
  • Leo YS; Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Leung CC; Members of ESGMYC.
  • Märtson AG; Public Health Consulting Group, Lugano, Switzerland.
  • Melazzini MG; Università Cattolica Sacro Cuore, Roma, Italy.
  • Najafi Fard S; Mater Olbia Hospital, Olbia, Italy.
  • Penttinen P; Members of ESGMYC.
  • Petrone L; Pediatric Clinic, Pietro Barilla Children's Hospital, University of Parma, Parma, Italy.
  • Petruccioli E; National Health Service, London, UK.
  • Pontali E; St George's, University of London, London, UK.
  • Saderi L; Members of ESGMYC.
  • Santin M; Tuberculosis Control Unit, Dept of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore.
  • Spanevello A; Scientific Direction, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.
  • van Crevel R; School of Medicine, University of Zagreb and Clinic for Respiratory Diseases, University Hospital Center Zagreb, Zagreb, Croatia.
  • van der Werf MJ; Members of ESGMYC.
  • Visca D; Sydney Pharmacy School, University of Sydney, Sydney, Australia.
  • Viveiros M; Westmead Hospital, Sydney, Australia.
  • Zellweger JP; Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia.
  • Zumla A; Public Health Emergency Team, European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Goletti D; European Centre for Disease Prevention and Control Public Health Emergency team co-authors.
Eur Respir J ; 56(4)2020 10.
Article in English | MEDLINE | ID: covidwho-890060
ABSTRACT
Major epidemics, including some that qualify as pandemics, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/09 and most recently COVID-19, affect the lung. Tuberculosis (TB) remains the top infectious disease killer, but apart from syndemic TB/HIV little is known regarding the interaction of viral epidemics and pandemics with TB. The aim of this consensus-based document is to describe the effects of viral infections resulting in epidemics and pandemics that affect the lung (MERS, SARS, HIV, influenza A (H1N1)pdm/09 and COVID-19) and their interactions with TB. A search of the scientific literature was performed. A writing committee of international experts including the European Centre for Disease Prevention and Control Public Health Emergency (ECDC PHE) team, the World Association for Infectious Diseases and Immunological Disorders (WAidid), the Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycobacterial Infections (ESGMYC) was established. Consensus was achieved after multiple rounds of revisions between the writing committee and a larger expert group. A Delphi process involving the core group of authors (excluding the ECDC PHE team) identified the areas requiring review/consensus, followed by a second round to refine the definitive consensus elements. The epidemiology and immunology of these viral infections and their interactions with TB are discussed with implications for diagnosis, treatment and prevention of airborne infections (infection control, viral containment and workplace safety). This consensus document represents a rapid and comprehensive summary on what is known on the topic.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Tract Infections / Tuberculosis / Virus Diseases Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Language: English Year: 2020 Document Type: Article Affiliation country: 13993003.01727-2020

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Tract Infections / Tuberculosis / Virus Diseases Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Language: English Year: 2020 Document Type: Article Affiliation country: 13993003.01727-2020